Bruno Schoentjes

Bruno Schoentjes has an extensive background in medicinal chemistry and oncology, with experience in leading complex drug discovery projects and teams. With a PhD in Biological chemistry, Bruno has held various roles in companies like Stemline Therapeutics, MENARINI Group, Bristol-Myers Squibb, and Janssen, contributing to medical strategy development, building medical affairs teams, managing clinical trials, and providing scientific support. Throughout their career, Bruno has demonstrated expertise in communicating medical scientific data, organizing medical education activities, and building partnerships within the healthcare industry.